A new analysis at OLYMP CDL: alpha-1 antitryptase

2015 began with the launch of a new analysis: alpha-1 antitryptase (A1AT). The enzyme is necessary for the complete diagnosis of lung (COPD, emphysema) and liver (hepatitis, cirrhosis) diseases. Epidemiological analysis have shown that disruption of the gene encoding A1AT production occurs in one in 2000 patients. Read more about the test here